Measuring HIV Quality of Care - Full Text View

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00012701

Purpose

The VA is the largest single provider of HIV care in the United States. The late 1990's have seen a revolution in the quality standards for this disease with the onset of Highly Active Antiretroviral Therapy (HAART) and other developments.

Condition
HIV Positive Facility Level Care Clinical Reminder

MedlinePlus related topics: AIDS

U.S. FDA Resources

Study Type:	Observational
Official Title:	Measuring HIV Quality of Care

Further study details as provided by Department of Veterans Affairs:

Estimated Enrollment:	1600
Study Completion Date:	June 2003

Groups/Cohorts
1

Detailed Description:

Background:

The VA is the largest single provider of HIV care in the United States. The late 1990's have seen a revolution in the quality standards for this disease with the onset of Highly Active Antiretroviral Therapy (HAART) and other developments.

Objectives:

Our purpose in this project is to develop a method for assessing quality in two important areas of HIV care - antiretroviral medications and opportunistic infection screening and prophylaxis - and explore the determinants of high quality care in order to suggest quality improvement strategies.

Methods:

The analysis has four parts. First, it will describe the level of adherence to the indicators in VA HIV patients nationwide and compare VA HIV patients to national benchmarks. Second, it will analyze facility and patient level predictors of adherence to indicators of quality of care and compare them with the predictors in the non VA population using staged logistic regressions. Third, it will seek to validate certain indicators (e.g. HAART therapy) against clinical outcomes like hospitalization and immune status. We will also model the clinical "price" that the VA pays in suboptimal clinical outcomes as a result of current performance levels. Fourth, we will compare the performance of the facilities after one year of an intensive targeted indicator-specific feedback group versus those receiving aggregate data only.

Status:

Data analysis.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: Facilities with HIV clinics Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00012701

Locations

United States, California
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073
VA San Diego Health Care System
San Diego, California, United States, 92161

Sponsors and Collaborators

Department of Veterans Affairs

Investigators

Principal Investigator:

Steven M. Asch, MD MPH

VA Greater Los Angeles Healthcare System

More Information

Publications:

Patterson ES, Nguyen AD, Halloran JP, Asch SM. Human factors barriers to the effective use of ten HIV clinical reminders. J Am Med Inform Assoc. 2004 Jan-Feb;11(1):50-9. Epub 2003 Oct 5.

Asch SM, Fremont AM, Turner BJ, Gifford A, McCutchan JA, Mathews WM, Bozzette SA, Shapiro MF. Symptom-based framework for assessing quality of HIV care. Int J Qual Health Care. 2004 Feb;16(1):41-50.

Bozzette SA, Phillips B, Asch S, Gifford AL, Lenert L, Menke T, Oritz E, Owens D, Deyton L. Quality Enhancement Research Initiative for human immunodeficiency virus/acquired immunodeficiency syndrome: framework and plan. HIV-QUERI Executive Committee. Med Care. 2000 Jun;38(6 Suppl 1):I60-9. Review.

Bozzette SA, Gifford AL. The economic viability of antiretroviral adherence interventions. Am J Med. 2003 Dec 1;115(8):672-3. No abstract available.

Responsible Party:	Department of Veterans Affairs ( Asch, Steven - Principal Investigator )
Study ID Numbers:	HIS 99-042
Study First Received:	March 14, 2001
Last Updated:	October 31, 2008
ClinicalTrials.gov Identifier:	NCT00012701 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Seropositivity
HIV Infections

Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:

Virus Diseases
Sexually Transmitted Diseases, Viral
RNA Virus Infections
Immune System Diseases
HIV Seropositivity

HIV Infections
Sexually Transmitted Diseases
Lentivirus Infections
Retroviridae Infections
Immunologic Deficiency Syndromes

ClinicalTrials.gov processed this record on May 06, 2009